World
Vaccine alliance secures deal for 500,000 mpox jabs for Africa

GENEVA — The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against mpox for use in African countries facing an epidemic of the virus.

The announcement came after the World Health Organization last week prequalified an mpox vaccine, MVA-BN, for the first time, paving the way for the United Nations and other international agencies to procure them.